Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljad390 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Laurence Pacot und 17 weiteren Autor:innen. Beteiligte Einrichtung: Fédération de Génétique et Médecine Génomique, Hôpital Cochin, DMU BioPhyGen, AP-HP, Centre-Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neurofibroma, Plexiform, Neurofibroma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Association Neurofibromatoses et Recklinghausen - Fondation CAP NF, INSERM, Assistance Publique-Hôpitaux de Paris.
Abstract (Originalsprache)
Background
Neurofibromatosis type 1 (NF1) is characterized by the highly variable and unpredictable development of benign peripheral nerve sheath tumours: cutaneous (cNFs), subcutaneous (scNFs) and plexiform (pNFs) neurofibromas.
Objectives
To identify neurofibroma modifier genes, in order to develop a database of patients with NF1.
Methods
All patients were phenotypically evaluated by a medical practitioner using a standardized questionnaire and the causal NF1 variant identified. We enrolled 1333 patients with NF1 who were genotyped for > 7 million common variants.
Results
A genome-wide association case-only study identified a significant association with 9q21.33 in the pNF phenotype in the discovery cohort. Twelve, three and four regions suggestive of association at the P ≤ 1 × 10–6 threshold were identified for pNFs, cNFs and scNFs, respectively. Evidence of replication was observed for 4, 2 and 6 loci, including 168 candidate modifier protein-coding genes. Among the candidate modifier genes, some were implicated in the RAS–mitogen-activated protein kinase pathway, cell-cycle control and myelination. Using an original CRISPR/Cas9-based functional assay, we confirmed GAS1 and SPRED2 as pNF and scNF candidate modifiers, as their inactivation specifically affected NF1-mutant Schwann cell growth.
Conclusions
Our study may shed new light on the pathogenesis of NF1-associated neurofibromas and will, hopefully, contribute to the development of personalized care for patients with this deleterious and life-threatening condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fédération de Génétique et Médecine Génomique, Hôpital Cochin, DMU BioPhyGen, AP-HP, Centre-Université Paris Cité, Paris, France.
- Institut Cochin, Inserm U1016, CNRS UMR8104, UFR de Pharmacie de Paris, Université Paris Cité, CARPEM, Paris, France.
- UMR 261 MERIT, Institut de Recherche pour le Développement, UFR de Pharmacie de Paris, Université Paris Cité, Paris, France.
- Service de Pathologie, Hôpital Cochin, AP-HP, Centre-Université Paris Cité, Paris, France.
- Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France.
- Institut Curie, INSERM U934/CNRS UMR3215, Paris Sciences et Lettres Research University, Sorbonne University, Paris, France.
ORCID-Profile: Jean-François Deleuze, Eric Pasmant
Förderung
- Association Neurofibromatoses et Recklinghausen - Fondation CAP NF
- INSERM
- Assistance Publique-Hôpitaux de Paris
Zitieren
APA
Pacot, L., Sabbagh, A., Sohier, P., Hadjadj, D., Ye, M., Boland-Auge, A., Bacq-Daian, D., Laurendeau, I., Briand-Suleau, A., Deleuze, J. F., Margueron, R., Vidaud, M., Ferkal, S., Parfait, B., Vidaud, D., NF-France Network, Pasmant, E., & Wolkenstein, P. (2024). Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad390
Vancouver
Pacot L, Sabbagh A, Sohier P, Hadjadj D, Ye M, Boland-Auge A, et al. Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljad390
BibTeX
@article{Pacot2024,
author = {Pacot, Laurence and Sabbagh, Audrey and Sohier, Pierre and Hadjadj, Djihad and Ye, Manuela and Boland-Auge, Anne and Bacq-Daian, Delphine and Laurendeau, Ingrid and Briand-Suleau, Audrey and Deleuze, Jean-François and Margueron, Raphaël and Vidaud, Michel and Ferkal, Salah and Parfait, Béatrice and Vidaud, Dominique and NF-France Network, NF-France Network and Pasmant, Eric and Wolkenstein, Pierre},
title = {Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljad390}
}
EUVIMED